Skip to content
Shuttingdown

Skye Bioscience, Inc.

Pharmaceutical Preparations · SAN DIEGO · CA

Distress signal

Moderate confidence (50%)

Updated Oct 20, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Skye Bioscience, Inc. received a delisting notice from its exchange (Aug 18, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Skye Bioscience, Inc. received a delisting notice from its exchange

    Aug 18, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 18, 2026 , Skye Bioscience, Inc. (the Company or Skye ) received a written notification ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the Company s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, the Company s stockholders equity was ($497,307), and therefore, the Company was not in compliance with Nasdaq Capital Market s Listing Rule 5550(b)(1), which requires a $2,500,…”
  2. Skye Bioscience, Inc. received a delisting notice from its exchange

    May 13, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 13, 2026 , Skye Bioscience, Inc. (the Company or Skye ) received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the Company s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, the Company s stockholders equity was $9,011,804, and therefore, the Company was not in compliance with Nasdaq Global Market s Listing Rule 5450(b)(1)(A), which requires a $10,000,000 minimu…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker SKYE on Nasdaq.
SEC CIK
0001516551
Website
ir.skyebioscience.comVerified from SEC EDGAR · Sep 23, 2026
LinkedIn
—
Headquarters
SAN DIEGO, CA
Also known as
Emerald Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC., Nemus Bioscience, Inc.
Legal entities
Skye Bioscience, Inc.

Sources

Every material source used to build this profile.

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 18, 2026 , Skye Bioscience, Inc. (the Company or Skye ) received a written notification ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the Company s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, the Company s stockholders equity was ($497,307), and therefore, the Company was not in compliance with Nasdaq Capital Market s Listing Rule 5550(b)(1), which requires a $2,500,…
    View source record
  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Skye Bioscience, Inc. — Pharmaceutical Preparations (SIC 2834) — SAN DIEGO, CA
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 13, 2026 , Skye Bioscience, Inc. (the Company or Skye ) received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the Company s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, the Company s stockholders equity was $9,011,804, and therefore, the Company was not in compliance with Nasdaq Global Market s Listing Rule 5450(b)(1)(A), which requires a $10,000,000 minimu…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 12:09 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.